Suerte, Judith M.

HRN: 27-64-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
CEFTRIAXONE 1G (VIAL)
08/15/2025
08/22/2025
IV
2gm
OD
CAP-MR
Remove - Pending Acceptance
08/15/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/15/2025
08/22/2025
PO
500mg
OD
CAP-MR
Remove - Pending Acceptance
08/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/15/2025
08/21/2025
IVT
4.5g 1st Dose Then 2.25g IVT Q6
Q6
CAP MR
Remove - Pending Acceptance
08/21/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/21/2025
08/27/2025
IV
4.5g
Q6
Capmr
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: